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Abstract
Background: Hypoxia plays a key role in ischaemic and neovascular disorders of the retina. Cellular responses to oxygen are
mediated by hypoxia-inducible transcription factors (HIFs) that are stabilised in hypoxia and induce the expression of a
diverse range of genes. The purpose of this study was to define the cellular specificities of HIF-1alpha and HIF-2alpha in
retinal ischaemia, and to determine their correlation with the pattern of retinal hypoxia and the expression profiles of
induced molecular mediators.
Methodology/Principal Findings: We investigated the tissue distribution of retinal hypoxia during oxygen-induced
retinopathy (OIR) in mice using the bio-reductive drug pimonidazole. We measured the levels of HIF-1alpha and HIF-2alpha
proteins by Western blotting and determined their cellular distribution by immunohistochemistry during the development
of OIR. We measured the temporal expression profiles of two downstream mediators, vascular endothelial growth factor
(VEGF) and erythropoietin (Epo) by ELISA. Pimonidazole labelling was evident specifically in the inner retina. Labelling
peaked at 2 hours after the onset of hypoxia and gradually declined thereafter. Marked binding to Mu ¨ller glia was evident
during the early hypoxic stages of OIR. Both HIF-1alpha and HIF-2alpha protein levels were significantly increased during
retinal hypoxia but were evident in distinct cellular distributions; HIF-1alpha stabilisation was evident in neuronal cells
throughout the inner retinal layers whereas HIF-2alpha was restricted to Mu ¨ller glia and astrocytes. Hypoxia and HIF-alpha
stabilisation in the retina were closely followed by upregulated expression of the downstream mediators VEGF and EPO.
Conclusions/Significance: Both HIF-1alpha and HIF-2alpha are activated in close correlation with retinal hypoxia but have
contrasting cell specificities, consistent with differential roles in retinal ischaemia. Our findings suggest that HIF-2alpha
activation plays a key role in regulating the response of Mu ¨ller glia to hypoxia.
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Introduction
Ischaemia is common to the major causes of blindness including
diabetes and retinopathy of prematurity. Ischaemia induces
powerful endogenous responses to protect against tissue injury,
including compensatory changes in blood flow, paracrine
expression of neurotrophic factors and angiogenesis. In the eye,
however, angiogenesis can be disorganised and typically results in
oedema and haemorrhage that adversely affect visual function.
There is an unmet need for therapies that promote endogenous
protective responses and prevent harmful angiogenesis. The
development of such strategies depends on a clear understanding
of oxygen sensing mechanisms in the retina and the roles of
downstream mediators.
The principal regulator of the transcriptional response to
hypoxia is the hypoxia-inducible factor (HIF) family of transcrip-
tion factors [1,2]. HIF is a heterodimeric transcription factor,
composed of one of the 3 oxygen-sensitive HIF-alpha subunits
(HIF-1alpha, HIF-2alpha and HIF-3alpha) and the oxygen-
insensitive and constitutively expressed HIF-beta subunit (ARNT)
In normoxic conditions hydroxylated HIF-alpha is bound to von
Hippel-Lindau protein (pVHL) and is targeted for ubiquitination
and subsequent proteosomal degradation [3–5]. Under hypoxic
conditions, dimerisation of the stabilised HIF-alpha subunit with
the HIF-beta subunit enables the transcriptional activity of a wide
range of genes including those involved in cellular metabolism,
hypoxia tolerance and angiogenesis, such as vascular endothelial
growth factor (VEGF) and erythropoietin (EPO) [6–8]. Although
the stabilisation of HIF-1alpha in hypoxia is largely controlled by
the inhibition of the VHL degradation pathway, an increase in
translation by stabilisation of HIF mRNA also occurs in certain
cell types [9–11]. The role of HIF-3alpha is yet to be clearly
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regulation of other HIF isoforms [12].
While HIF-1alpha and HIF-2alpha subunits are highly
homologous and structurally similar in their DNA binding and
dimerisation domains, they have distinct roles both during
development [13–15] and in adaptive responses to hypoxia
[8,11,16,17]. Their dissimilar roles may reflect differences in
cellular distribution[11,16], transcriptional regulation [18,19] and
co-activation or repression [20]. Evidence from in vitro studies
suggests that HIF-1alpha responds only to severe hypoxia whereas
HIF-2alpha is stabilised in relatively moderate hypoxia [11]. The
cellular distributions of HIF-alpha isoforms within the hypoxic
retina, and their relative timecourses of stabilisation are not clearly
defined. The purpose of the present study was to compare the
cellular specificities of HIF-1alpha and HIF-2alpha in retinal
ischaemia, and to determine their spatiotemporal correlation with
retinal hypoxia and the expression profiles of induced molecular
mediators. The results demonstrate that both HIF-1alpha and
HIF-2alpha are upregulated by post-translational stabilization in
close correlation with hypoxia but have dissimilar cellular
specificities. The distinct spatial distributions of HIFs provide
further evidence that HIF-1alpha and HIF-2alpha have isoform-
specific roles in cellular adaptation to hypoxia in the retina.
Results and Discussion
The spatial and temporal pattern of hypoxia in OIR
To investigate the effect of hypoxia on the HIF pathway in the
retina we used a well-characterised mouse model of oxygen-
induced retinopathy (OIR) [21]. Briefly, mice exposed to 75%
oxygen from postnatal day 7 (p7) to p12 develop areas of retinal
capillary obliteration; on return to room air at p12 the ischaemic
retina becomes hypoxic until it is revascularised at around p26. To
determine the tissue distribution and timecourse of hypoxia in
relation to vascularisation, we co-stained flatmounted retinas of
animals at intervals during OIR development with the hypoxia
marker pimonidazole and the vascular endothelial marker BS
lectin. Previous studies in animal models have demonstrated that
oxygen tensions can fall below 5 mmHg in the ischemic retina
[22–24], a level well within the detection range of pimonidazole
that forms an adduct with hypoxic proteins at a pO2 of less than
10 mmHg [25–28].
In animals at p12 still in 75% oxygen, the absence of
pimonidazole labelling indicated no areas of retinal hypoxia
(Figure 1A). In animals 2 hours following return to room air,
strong pimonidazole labelling was evident throughout the retina
indicated hypoxia of less than 10 mmHg. Hypoxia was evident not
only within the ischaemic regions but also, to a lesser extent, in
areas of persistent vascularisation. (Figure 1B). Six to 24 hours
following return to room air, pimonidazole labelling was limited
specifically to areas of capillary ablation in the central retina
(Figure 1C and D). At p17 small areas of pimonidazole staining
indicated hypoxia in persistently ischemic areas (Figure 1E). At
p26 the retina was fully revascularised and there was no evidence
of persistent hypoxia (Figure 1F). In animals at p12 that had been
raised in room air throughout, pimonidazole staining evident only
in the far retinal periphery indicated the physiologically low
oxygen tension that is associated with normal retinal vascular
development (Figure 1G).
The extent of hypoxia detection in the retina following OIR is
consistent with results of other studies of murine and rat OIR [26–
30] and further defines the temporal and spatial pattern of hypoxia
in relation to vascular ablation and recovery in this model. In
addition, we observed that during the first few hours after return to
room air, retinal hypoxia extends well beyond the areas of
capillary loss. The subsequent restriction of pimonidazole staining
specifically to area of ischaemia suggests that hypoxia within
vascularised regions is rapidly redressed by compensatory
mechanisms, and we speculate that this may involve autoregula-
tion of the inner retinal vascular supply.
To examine the distribution of hypoxia across the retinal layers
we stained retinal sections from animals 2 hours following return
to room air with pimonidazole. Staining was localised primarily to
the inner retina, extending from the inner retinal surface to the
outer border of the outer plexiform layer (Figure 1H and I). These
findings are consistent with the considerable reduction in inner
retinal oxygenation measured using micro-electrodes within the
normal retina [31], and the pattern of hypoxia is consistent with
measurements of retinal oxygenation during occlusions of the
inner retinal circulation [32]. The relative specificity of pimoni-
dazole labelling of the inner retina is consistent with insufficiency
of the retinal circulation with sparing of the choroidal circulation
that can support highly metabolically active photoreceptors but is
insufficient to meet the oxygen demands of the inner retina [27].
At high magnification, pimonidazole staining in the outer retina
was evident as linear processes extending through the outer
nuclear layer and terminating at the outer limiting membrane. Co-
localisation with the Mu ¨ller cell marker glutamine synthetase
indicated that these are processes of Mu ¨ller glia. (Figure 1J;
magnified in K) The presence of pimonidazole positive Mu ¨ller cell
processes in the outer nuclear layer may reflect intracellular
movement of hypoxic adducts from the inner retina during the 3-
hour period between pimonidazole administration and analysis.
The spatial and temporal distribution of HIF-1alpha and
HIF-2alpha in OIR
To compare the tissue distribution of HIF-1alpha and HIF-
2alpha with that of hypoxia we performed immunohistochemistry
on retinal sections in mice 2 hours following return to room air. At
this timepoint, immunostaining for both HIF-1alpha (Figure 2A
and B) and HIF-2alpha (Figure 2C and D) was evident in the inner
retina, and was more prominent in the central retina than in the
periphery. The tissue distributions are consistent with the
stabilisation of HIFs in areas of retinal hypoxia indicated by
pimonidazole labelling in retinal flatmounts.
To investigate the detailed cellular specificities and timecourses
of HIF-1alpha and HIF-2alpha in retinal ischaemia we examined
sections of central retina from mice at intervals following return
from hyperoxia to room air. In animals at p12 still in 75% oxygen,
immunostaining for both HIF-1alpha and HIF-2alpha was
detected at low levels in the inner retina (Figure 3A and G)
comparable to staining in mice raised in room air throughout
(Figure 3 M, N). Two hours following return to room air, HIF-
1alpha and HIF-2alpha proteins were strongly evident in nuclei of
cells in the inner retina (Figure 3B and H). Similar staining was
observed at 6 and 24 hours (HIF-1alpha: Figure 3C and D, HIF-
2alpha: Figure 3I and J). After 5 days following return to room air
the degree of HIF-alpha staining was considerably reduced
(Figure 3E and K), and after 2 weeks was comparable to baseline
(Figure 3F and L compared with 3A and 3G).
Stabilisation of both HIF-1alpha and HIF-2alpha was restricted
to the inner retina. Evidence of HIF-1alpha and HIF-2alpha in the
outer retina was weak throughout OIR, consistent with the
provision of oxygen to photoreceptor cells by the uncompromised
choroidal circulation. This pattern of HIF regulation is in contrast
to the effect of systemic hypoxia in which upregulation of HIF-
1alpha extends across the outer retina [33].
HIF-alpha in Retinal Ischaemia
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contrasting cellular distributions within the inner retina. HIF-
1alpha staining was prominent in cells across the inner nuclear
layer and in retinal ganglion cells. In contrast, HIF-2alpha was
highly restricted to a discrete layer of cells within the inner nuclear
layer, and to occasional astrocytes in the nerve fibre layer.
Immunostaining of an adjacent section for the Mu ¨ller cell marker
glutamine synthetase at p17 demonstrated a very similar
distribution of cells (Figure 3P), strongly suggesting that upregula-
tion of HIF-2alpha in this model is specific to Mu ¨ller glia.
The temporal correlation of HIF-1alpha and HIF-2alpha
RNA and protein in OIR with the upregulated expression
of downstream mediators VEGF and Epo
To investigate the expression of HIF-1alpha and HIF-2alpha in
OIR we performed real-time RT-PCR on retinal cDNA from
animals at p13. Total retinal HIF-1alpha was significantly greater
than HIF-2alpha in both normoxia and OIR (Figure 4A). OIR was
associated with no significant effect on the amount of either HIF-
1alpha or HIF-2alpha RNA detected in the retina (Figure 4A) but
caused a dramatic increase in the amount of HIF-1alpha and HIF-
2alpha protein (Figure 4B–E) that correlated closely with
the time course of protein upregulation demonstrated by
immunohistochemistry.
Evaluation of HIF-alpha proteins by Western blotting suggested
a subtle increase immediately on removal from hyperoxia (4B and
4C; p12+0 h). This most likely reflects the rapid response of the
HIF system to the brief period of relative hypoxia in room air prior
to tissue processing. HIF-alpha is stabilised within 1–2 hours of
hypoxia in vivo [16,17] and can accumulate within minutes [34,35].
Alternatively, the subtle increase in HIF-alpha proteins at this time
point may reflect hypoxia-independent mechanisms of HIF
stabilisation by reactive oxygen species [36] or cytokines [8].
The lack of a detectable effect of OIR on RNA levels of either
HIF-alpha isoform demonstrates that the upregulation and
differential distribution of HIF-1alpha and HIF-2alpha transcrip-
tion factors in retinal ischaemia result primarily from cell type and
protein specific post-translational stabilisation, and not from
differentially upregulated expression. This is consistent with the
mechanisms described in acute hypoxia in the retina [35] and in
other tissues, [17,37] though increased stabilisation of mRNA may
be involved in the retinal response to sustained systemic hypoxia
[38].
To investigate the consequences of HIF-1alpha and HIF-2alpha
activation in the retina we investigated the expression time-courses
of their downstream mediators VEGF and Epo. The levels of both
VEGF and Epo proteins in the whole eye were rapidly and
significantly upregulated from p12 to p17. The profiles of protein
upregulation were closely correlated to the timing of both HIF-
1alpha and HIF-2alpha stabilisation in the retina (Figure 4F, G)
and suggest no clear difference in transcriptional targeting.
HIF-1alpha is ubiquitously expressed. We found that HIF-
1alpha is stabilised throughout the hypoxic inner retina, in
ganglion cells and those of the inner nuclear layer, consistent with
the distribution of HIF-1alpha described in previous reports
[39,40]. HIF-1alpha stabilisation in neuronal cells has been shown
to be important for cell survival in the hypoxic brain [41] and
retina [42,43]. Therefore, in retinal ischaemia, HIF-1alpha
stabilisation may have an important role in neuroprotection.
HIF-2alpha was originally identified in vascular endothelial cells
but is also expressed in a range of cells including interstitial cells
and astrocytes [37,44]. In the mouse retina, the expression of a
surrogate marker suggests that HIF-2alpha is expressed by cells in
the ganglion cell layer, inner nuclear layer and retinal pigment
epithelium [45]. We have found that HIF-2alpha is expressed at a
higher level than HIF-1alpha in the retina, and during retinal
ischaemia is specifically activated in restricted populations of cells
within the area of inner retinal hypoxia, consistent with Mu ¨ller glia
in the inner nuclear layer and astrocytes in the nerve fibre layer.
Interestingly, the expression of both VEGF mRNA and Epo
during ischaemia in OIR have a strikingly similar non-uniform
distribution, with expression highly localized to cells in the centre
of the inner nuclear layer and in the nerve fibre layer [39,40,46].
Recent data demonstrate that Mu ¨ller cell derived VEGF is a
significant contributor to retinal neovascularisation in OIR [47].
Our findings suggest that the response of Mu ¨ller cells to hypoxia is
mediated by activation of HIF-2alpha and provide the basis for
future mechanistic and interventional studies.
HIF-2alpha mediates powerful angiogenic and neuroprotective
responses to hypoxia. Haploinsufficiency of HIF-2alpha results in
blunted induction of both VEGF and Epo, and reduced retinal
neovascularisation in OIR [48]. HIF-2 is specifically responsible
for the hypoxic upregulation of Epo [40,49,50] that may promote
astrocytic paracrine-dependent neuronal survival during ischaemia
[44,51–54]. In the retina, HIF-2alpha induced expression of Epo
may be responsible for the neuroprotective effect of hypoxic
preconditioning [33]. HIF-2alpha has also been implicated
mitochondrial homeostasis and regulation of antioxidant enzymes
[55]. In the retina, deficiency of HIF-2alpha results in a retinal
phenotype similar to oxidative-stress induced mitochondrial
disease. [45]
This study demonstrates that both HIF-1alpha and HIF-2alpha
are activated in close correlation with retinal hypoxia but have
contrasting cell specificities within the inner retina. The findings
suggest that HIF-1alpha and HIF-2alpha have differential roles in
retinal ischaemia, and specifically that HIF-2alpha activation plays
a key role in regulating the response of Mu ¨ller glia to hypoxia.
Methods
Animals
All animals were used with University College London ethics
committee approval and under a UK Home Office project licence
Figure 1. Temporal and spatial distribution of hypoxia throughout oxygen-induced retinopathy (OIR) development. Representative
retinal flatmounts throughout OIR development are shown in A–G (magnification 65) co-stained for hypoxia (pimonidazole, green) and vasculature
(Bandeiriae simplicifolia lectin, red); A, 0 h; B, 2 h; C, 6 h; D, 24 h (p13); E, 5 days (p17); F, 14 days (p26); G, normoxic control. Representative retinal
cryosections at the p12+2 h timepoint are shown in detail in H–M. Marked pimonidazole staining (green) was evident in the inner retina, and was
strongest in the central region corresponding with ischaemia (H, magnification620; I, magnification663). Strong pimonidazole staining was evident
in all tissue layers of the inner retina including the outer plexiform layer. Pimonidazole staining apparent in a linear radial configuration in the outer
retina co-localised closely with the Mu ¨ller glial marker glutamine synhetase (red) (x40 magnification J, enlarged in K). A section incubated without
glutamine synthetase primary antibody is shown in L (magnification 640), enlarged in M. and minimal staining was detected in the outer nuclear
layer and retinal pigment epithelium. ONH = optic nerve head, OS = ora serrata, gcl = ganglion cell layer, inl = inner nuclear layer, opl = outer
plexiform layer, onl = outer nuclear layer, rpe = retinal pigment epithelium. Scale bars: in A (for A–G) =500 mm, H=250 mm, I, J, L=50 mm, K,
M=10mm.
doi:10.1371/journal.pone.0011103.g001
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dance with the Association for Research in Vision and
Ophthalmology Statement for the Use of Animals in Ophthalmic
and Vision Research.
The mouse model of oxygen-induced retinopathy (OIR)
Nursing mothers and their pups were placed in a 75% oxygen
supply chamber from postnatal day 7 to postnatal day 12 as
previously described [21]. A constant low flow of 80% oxygen,
balance nitrogen was provided to a closed perspex chamber. The
oxygen level was monitored, and maintained at 75% +/2 3% O2.
Mice were checked twice daily, the mothers were removed from
the chamber to breathe room air (21% oxygen) for a minimum of
2 hours a day to minimise lung toxicity associated with hyperoxia
in adults. Food, water and bedding were changed every 2 days.
The mice were exposed to a standard 12 hour light-dark cycle,
and all euthanasia was performed in the light.
Immunohistochemistry for pimonidazole
(Hypoxyprobe
TM)
60 mg/kg bodyweight pimonidazole hydrochloride (Hypoxyp-
robe-1
TM kit, Chemicon (Millipore), Livingston UK) diluted in
sterile phosphate buffered saline (PBS, Invitrogen Ltd. Paisley UK)
was administered by intraperitoneal injection 3 hours prior to
euthanasia as previously described [26]. Animals were terminally
anaesthetised and eyes were fixed by intracardiac perfusion with
1% paraformaldehyde in PBS pH 7.4 and post fixed in 1-4%
paraformaldehyde at room temperature. Retinal cryosections were
incubated for 1 hour at room temperature in PBS with 1% bovine
serum albumin (BSA, Sigma Aldrich Ltd. Gillingham, UK) and
5% normal goat serum (Abd serotec, Kidlington UK) and for
retinal flatmounts, 0.05% (v/v) Triton X-100 (Sigma Aldrich Ltd.,
Gillingham UK) was added to the blocking solution. For retinal
cryosection analysis (n=3 eyes for each time-point), 12 mm retinal
sections were incubated with anti-pimonidazole antibody (FITC
conjugated mouse anti pimonidazole in Hypoxyprobe-1
TM kit,
Chemicon, Millipore Ltd. Livingston UK) at 1:50 dilution in
blocking solution for 1 hour at room temperature. For retinal
flatmount examination (n=3 eyes for each time-point), eyecups
with the cornea and lens removed were incubated with anti-
pimonidazole antibody at a dilution of 1:100 in blocking solution
for 4 hours at 37uC. Counterstaining with TRITC conjugated
Bandeiraea simplicifolia (BS) lectin (Sigma Aldrich, Gillingham, UK)
was performed at a concentration of 0.1 mg/ml in PBS overnight
at 4uC. Retinas were washed extensively in PBS and dissected
from the eyecup, radial cuts were made to flatten the retina, and
the retinas were mounted with fluorescent aqueous mounting
medium (Dako Ltd., Ely UK) ganglion cell layer uppermost using
a coverslip.
HIF-1alpha and HIF-2alpha immunohistochemistry
Following terminal anaesthesia (pentobarbital, Euthatal
TM
Merial Animal Health Ltd. Harlow, UK) eyes were fixed by
intracardiac perfusion with ice-cold neutral buffered 10% (v/v)
formalin. Post fixation was performed for 24 hours using formalin
at 4uC, followed by 100% ethanol for 24 hours at 4uC. Eyes (n=3
eyes for each time-point), were processed in an automated
machine (Leica TP1020) then embedded in paraffin blocks for
sectioning. Sections were cut on a microtome at 6 microns, and
Figure 2. Spatial distribution of HIF-1alpha and HIF-2alpha in
the early hypoxic phase of OIR. Immunohistochemistry for HIF-
1alpha and HIF-2alpha was performed on 6 mm paraffin sections of eyes
from animals that had undergone OIR, culled 2 hours after removal
from hyperoxia (p12+2 h, n=6 independent eyes). The secondary
antibody was detected by DAB staining. Masson’s light green was used
as a connective tissue counterstain. HIF-1alpha was detected through-
out the inner retina, particularly in the central central region
corresponding to the area of greatest hypoxia (x20 magnification
shown in A, and 640-magnified images shown in B). The spatial
distribution of HIF-2alpha on an adjacent retinal section was very similar
but restricted to a small number of cells of the inner retina (x20
magnification shown in C, 640 magnified images shown in D). A serial
section incubated without primary antibody showed no specific
staining (Figure 2E and F). ONH = optic nerve head, gcl = ganglion
cell layer, inl – inner nuclear layer, onl = outer nuclear layer. Scale bars:
in A (for A, C, E): 500 mm, in B (for B, D, F): 50 mm.
doi:10.1371/journal.pone.0011103.g002
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ough, UK). Antigen retrieval was performed using a commercial
target retrieval solution (Dako Ltd., Ely UK) at 120uC.
Immunohistochemistry was performed using a commercial signal
amplification kit (Dako Ltd., Ely UK) according to the
manufacturer’s instructions, with diamino benzidine (DAB) as
the final substrate. Primary antibodies and dilutions used are
shown in Table 1. Primary antibodies were diluted in commercial
antibody diluent (Dako Ltd., Ely UK) and were incubated at room
temperature for 1 h as part of the signal amplification protocol.
Sections were counterstained with either Masson’s light green
(staining connective tissue) or haematoxylin (staining nuclei), and
mounted using DPX (VWR, Leicester UK).
Other paraffin immunohistochemistry
Antibody staining for the Mu ¨ller glial cell marker Glutamine
Synthetase (GS) was performed at a concentration of 1:100 after
antigen retrieval as detailed above (mouse MAb anti-Glutamine
Synthetase, BD Transduction Laboratories, Oxford UK). Blocking
and primary antibody incubation was performed in 4% (v/v) NGS
1% (w/v) BSA PBS tween 0.05% (Sigma Aldrich, Gillingham UK)
for 1 hour at room temperature. The primary antibody was
biotinylated (Animal Research Kit, Dako UK Ltd.) and DAB was
used as the final substrate after streptavadin-horseradish
peroxidase incubation according to the manufacturer’s
recommendations.
Real-time RT PCR
RNA was extracted from mouse tissue (n=3 eyes for each
group) using a commercial kit (RNeasy mini kit, Qiagen Ltd.
Crawley UK). Tissue for RNA extraction was placed directly in
lysis solution for immediate RNA purification, or placed in RNA
stabilisation solution (RNAlater, Ambion, Warrington UK) and
stored at 4uC for up to 2 weeks until RNA purification. Purified
RNA was stored in DEPC treated water (Invitrogen Ltd. Paisley
UK) at 280uC until use. The amount of template RNA was
measured using a commercial small-volume spectrophotometer
(Nanodrop ND-1000, ThermoScientific, Wilmington, DE USA).
Figure 3. Temporal distribution of HIF-1alpha and HIF-2alpha throughout OIR development. Immunohistochemistry for HIF-1alpha (A–F)
and HIF-2alpha (G–L) was performed throughout OIR development, using DAB staining and haematoxylin counterstain. The central region (2 high
power fields from the optic nerve head) from central retinal sections at 640 magnification is shown. Normoxic controls at p12 are shown for HIF-
1alpha (M) and HIF-2alpha (N). A section at p12+2 h is shown where the primary antibody was omitted is shown in O; the laminar dark brown
appearance in the outer retina reflects pigment in the retinal pigment epithelium and choroid. Immunohistochemistry for the Mu ¨ller cell marker
glutamine synthetase performed on a serial section at p17 (P) strongly suggests that the upregulation of HIF-2alpha in this model is highly restricted
to Mu ¨ller glia. Figure 3Q shows a serial section to P, incubated with a non-targeting IgG control primary antibody raised in the same species as the
anti-glutamine synthetase antibody. Gcl = ganglion cell layer, inl = inner nuclear layer, onl = outer nuclear layer. Scale bar in A: 50 mm.
doi:10.1371/journal.pone.0011103.g003
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Antigen Species and source of antibody Use Dilution
HIF-1alpha Polyclonal rabbit anti-HIF-1alpha
(Novus biologicals, Littleton USA) [16]
Immuno-histochemistry and
western blotting
1:10 000 (IHC)
1: 500 (WB)
HIF-2alpha PM8 rabbit antiserum [37] Immuno-histochemistry 1:20 000
HIF-2alpha PM9 rabbit antiserum [37] Western blotting 1:2000
b-actin Monoclonal mouse anti-b-actin (Sigma Aldrich, Gillingham UK) Western blotting 1:5000
doi:10.1371/journal.pone.0011103.t001
Figure 4. HIF-alpha expression and protein stabilisation in OIR and relation to ocular VEGF and Epo expression. Retinal RNA was
isolated from eyes taken at p13 from animals which had undergone OIR (n=3) and age-matched normoxic controls (n=3). RT-PCR standard curves
were generated and Ct values of normoxic and hypoxic retinal cDNA were compared to the standard curves (A). Western blots for HIF-1alpha (B) and
HIF-2alpha (C) on retinal protein extracts showed that both proteins were strongly upregulated within 2 h of hypoxia. HIF-1alpha was detected as
multiple bands, whereas HIF-2alpha was detected as a single band. HIF-alpha upregulation was maintained at p17 but not by p26. mVEGFA,
measured by ELISA (D), was significantly upregulated within 6 hours of return to room air, reaching a peak at 24 hours. mEpo, (E), was also maximally
upregulated at 24 hours although the induction of mEpo was less profound and more variable than mVEGFA. Levels of both proteins returned to
normoxic levels by p26. ELISA values are expressed as concentration (pg/ml) per milligram of whole eye protein. * p,0.05, **p,0.01, *** p,0.001
unpaired t test in A, one-way ANOVA compared with p12 normoxia in D, E. p = postnatal day + time after removal from hyperoxia, norm = normoxia
p12. In D and E, the number of eyes analysed at each time-point is noted within the bar in each graph. Graphs showmean 6 SEM.
doi:10.1371/journal.pone.0011103.g004
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equal amounts of RNA were used for all samples as a template for
cDNA manufacture. cDNA was made from template RNA using a
commercial kit (Quantitect Reverse Transcriptase kit, Quiagen
Ltd. Crawley UK). cDNA was stored at 220uC until use. Real-
time quantitative RT-PCR was performed using a commercial
thermal-cycler (Applied Biosciences 7900HT) with its associated
software (Applied Biosciences SDS version 2.2.2). Real-time PCR
reagents were all obtained commercially (Roche Diagnostics Ltd.,
Burgess Hill, UK). The 59 nuclease technique based on Taq-
polymerase and FAM labelled hydrolysis probes was used for all
real-time reactions using commercially designed primer/probe
combinations (Roche Universal Probe Library). Sequences and
accession numbers used for primers and probes detecting mHIF-
1alpha, mHIF-2alpha and mb-actin are shown in Table 2. All
reactions were performed in duplicate or triplicate. For all test
samples, the endogenous control b-actin was used to verify equal
loading and to facilitate relative quantitation calculation. Endog-
enous control samples were loaded on the same plate as the test
samples, from the same aliquot of cDNA. A water-only control
sample was included for each primer/probe combination on each
test plate to verify the lack of contaminants in the mixture. For
each experiment, a suitable control sample was used to compare
the test samples. Amplicon-specific standard curves were produced
using mHIF-1alpha and mHIF-2alpha DNA of known concen-
tration. Ct values of the samples were compared to the standard
curves and resultant cDNA concentrations were expressed in pg/
ml. The -DCt method of relative quantitation was used to compare
data, and only data from samples in a single plate run at the same
time were compared statistically.
Western blotting
Retinal tissue (pooled from 4 eyes for each time-point) was lysed
using a commercial buffer (RIPA, Sigma Aldrich, Gillingham,
UK) with added protease inhibitor cocktail (Sigma Aldrich,
Gillingham, UK). Cell membranes were disrupted using a
sonicator with a micro-tip (Soniprep 150, MSE London UK).
Lysates were archived at 280uC. Equal amounts of protein were
run on a 7.5% (w/v) reducing SDS polyacrylamide electrophoresis
gel. After transfer to PVDF membrane (Millipore Watford UK)
and blocking in 5% (w/v) non fat milk, 1% (w/v) bovine serum
albumin in PBST, membranes were incubated with primary
antibodies as detailed in Table 1. After washing in PBST,
secondary antibody was incubated at a concentration of 1:5000 -
1:10 000 for 1 hour at room temperature (Pierce Immunopure
goat anti-rabbit and anti-mouse IgG (H+L) HRP conjugated,
Perbio Science UK Ltd., Northumberland UK). Chemilumines-
cence detection was performed using a Fujifilm LAS-1000
Luminescence Image Analyser after incubation with enhanced
luminescence reagent (ECL plus GE Healthcare UK Ltd.
Amersham, UK). Western blots were all performed in duplicate.
ELISA for mVEGFA and mEpo
Whole eyes were collected from mice and snap frozen in liquid
nitrogen. Eyes were homogenised in sterile PBS with protease
inhibitors (Sigma Aldrich, Gillingham UK) using a glass
homogeniser. The homogenate was spun at 7000rpm for 10
minutes. Protein concentration of the supernatant was measured
using a Lowry-based colorimetric protein assay performed in
triplicate (DC protein assay kit, Bio-Rad, Hemel Hempstead UK)
compared to a bovine serum albumin standard curve. Sample
endpoint ELISA was measured in triplicate using a microplate
reader (Emax, Molecular Devices Ltd. Berkshire UK) comparing
the optical density at 450 nm with a reference at 650 nm. The
combined quantity of murine VEGF-A 164 and 120 splice variants
(Mouse VEGF DuoSet ELISA development kit, R and D Systems
Europe Abingdon UK) or murine erythropoietin (Mouse erythro-
poietin Quantikine ELISA development kit, R and D Systems) was
calculated per milligram of whole eye protein comparing each
sample to a standard curve of known concentration.
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